Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Division of Neuroradiology, Brigham and Women's Hospital, Boston, Massachusetts.
Neurosurgery. 2018 Feb 1;82(2):E32-E34. doi: 10.1093/neuros/nyx510.
QUESTION 1: What sequences should be obtained on magnetic resonance imaging (MRI) to evaluate vestibular schwannomas before and after surgery?
Adults with vestibular schwannomas.
Initial Preoperative Evaluation Level 3: Imaging used to detect vestibular schwannomas should use high-resolution T2-weighted and contrast-enhanced T1-weighted MRI. Level 3: Standard T1, T2, fluid attenuated inversion recovery, and diffusion weighted imaging MR sequences obtained in axial, coronal, and sagittal plane may be used for detection of vestibular schwannomas. Preoperative Surveillance Level 3: Preoperative surveillance for growth of a vestibular schwannoma should be followed with either contrast-enhanced 3-dimensional (3-D) T1 magnetization prepared rapid acquisition gradient echo (MPRAGE) or high-resolution T2 (including constructive interference in steady state [CISS] or fast imaging employing steady-state acquisition [FIESTA] sequences) MRI. Postoperative Evaluation Level 2: Postoperative evaluation should be performed with postcontrast 3-D T1 MPRAGE, with nodular enhancement considered suspicious for recurrence.
QUESTION 2: Is there a role for advanced imaging for facial nerve detection preoperatively (eg, CISS/FIESTA or diffusion tensor imaging)?
Adults with proven or suspected vestibular schwannomas by imaging.
Level 3: T2-weighted MRI may be used to augment visualization of the facial nerve course as part of preoperative evaluation.
QUESTION 3: What is the expected growth rate of vestibular schwannomas on MRI, and how often should they be imaged if a "watch and wait" philosophy is pursued?
Adults with suspected vestibular schwannomas by imaging.
Level 3: MRIs should be obtained annually for 5 yr, with interval lengthening thereafter with tumor stability.
QUESTION 4: Do cystic vestibular schwannomas behave differently than their solid counterparts?
Adults with vestibular schwannomas with cystic components.
Level 3: Adults with cystic vestibular schwannomas should be counseled that their tumors may more often be associated with rapid growth, lower rates of complete resection, and facial nerve outcomes that may be inferior in the immediate postoperative period but similar to noncystic schwannomas over time.
QUESTION 5: Should the extent of lateral internal auditory canal involvement be considered by treating physicians?
Adult patients with vestibular schwannomas.
Level 3: The degree of lateral internal auditory canal involvement by tumor adversely affects facial nerve and hearing outcomes and should be emphasized when interpreting imaging for preoperative planning.
QUESTION 6: How should patients with neurofibromatosis type 2 (NF2) and vestibular schwannoma be imaged and over what follow-up period?
Adult patients with NF2 and vestibular schwannomas.
Level 3: In general, vestibular schwannomas associated with NF2 should be imaged (similar to sporadic schwannomas) with the following caveats: 1. More frequent imaging may be adopted in NF2 patients because of a more variable growth rate for vestibular schwannomas, and annual imaging may ensue once the growth rate is established. 2. In NF2 patients with bilateral vestibular schwannomas, growth rate of a vestibular schwannoma may increase after resection of the contralateral tumor, and therefore, more frequent imaging may be indicated, based on the nonoperated tumor's historical rate of growth. 3. Careful consideration should be given to whether contrast is necessary in follow-up studies or if high-resolution T2 (including CISS or FIESTA-type sequences) MRI may adequately characterize changes in lesion size instead.
QUESTION 7: How long should vestibular schwannomas be imaged after surgery, including after gross-total, near-total, and subtotal resection?
Adult patients with vestibular schwannomas followed after surgery.
Level 3: For patients receiving gross total resection, a postoperative MRI may be considered to document the surgical impression and may occur as late as 1 yr after surgery. For patients not receiving gross total resection, more frequent surveillance scans are suggested; annual MRI scans may be reasonable for 5 yr. Imaging follow-up should be adjusted accordingly for continued surveillance if any change in nodular enhancement is demonstrated. The full guideline can be found at https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter_5.
问题 1:在手术前后评估前庭神经鞘瘤时,应获取哪些磁共振成像(MRI)序列?
患有前庭神经鞘瘤的成年人。
初始术前评估 3 级:用于检测前庭神经鞘瘤的成像应使用高分辨率 T2 加权和对比增强 T1 加权 MRI。3 级:可在轴位、冠状位和矢状位获得标准的 T1、T2、液体衰减反转恢复和弥散加权成像 MR 序列,用于检测前庭神经鞘瘤。术前监测 3 级:应通过对比增强 3 维(3-D)T1 磁化准备快速获取梯度回波(MPRAGE)或高分辨率 T2(包括稳态构建干扰[CISS]或稳态采集的快速成像[FIESTA]序列)MRI 对前庭神经鞘瘤的生长进行术前监测。术后评估 2 级:术后评估应使用对比增强 3-D T1 MPRAGE 进行,结节增强被认为是复发的可疑征象。
问题 2:术前高级影像学检查(例如 CISS/FIESTA 或弥散张量成像)对面神经检测是否有作用?
通过影像学证实或怀疑患有前庭神经鞘瘤的成年人。
3 级:T2 加权 MRI 可用于增强面神经走行的可视化,作为术前评估的一部分。
问题 3:在采用“观察等待”策略时,MRI 上前庭神经鞘瘤的预期增长率是多少,应多长时间进行一次成像?
通过影像学怀疑患有前庭神经鞘瘤的成年人。
3 级:前 5 年每年进行 MRI 检查,此后根据肿瘤稳定性延长间隔。
问题 4:囊变的前庭神经鞘瘤与实性肿瘤有何不同?
有囊变成分的前庭神经鞘瘤的成年人。
3 级:应告知患有囊变前庭神经鞘瘤的成年人,他们的肿瘤可能更常与快速生长、更低的完全切除率以及术后即刻面神经结局较差有关,但随着时间的推移,与非囊变神经鞘瘤的结果相似。
问题 5:治疗医生是否应该考虑外侧内听道受累的程度?
患有前庭神经鞘瘤的成年患者。
3 级:肿瘤对外侧内听道的累及程度会对面神经和听力结果产生不利影响,在为术前规划进行影像学解读时应强调这一点。
问题 6:如何对患有神经纤维瘤病 2 型(NF2)和前庭神经鞘瘤的患者进行成像以及随访多长时间?
患有 NF2 和前庭神经鞘瘤的成年患者。
3 级:一般来说,应(与散发性神经鞘瘤相似)对 NF2 相关的前庭神经鞘瘤进行成像,但有以下注意事项:1. 由于 NF2 患者前庭神经鞘瘤的生长速度可能存在差异,因此可能会采用更频繁的成像方式,一旦确定了生长速度,每年进行一次成像即可。2. 在 NF2 患者双侧前庭神经鞘瘤中,对侧肿瘤切除后,肿瘤的生长速度可能会增加,因此,根据未手术肿瘤的历史生长速度,可能需要更频繁的成像。3. 在随访研究中是否需要对比剂,或者高分辨率 T2(包括 CISS 或 FIESTA 型序列)MRI 是否足以描述病变大小的变化,应仔细考虑。
问题 7:前庭神经鞘瘤手术后应在多长时间内进行成像,包括全切除、近全切除和次全切除后?
接受过前庭神经鞘瘤手术的成年患者。
3 级:对于接受全切除的患者,可能需要进行术后 MRI 以记录手术印象,并且可以在术后 1 年进行。对于未接受全切除的患者,建议更频繁地进行监测扫描;对于 5 年,每年进行 MRI 扫描可能是合理的。如果显示结节增强有任何变化,应相应调整影像学随访以继续监测。
完整的指南可以在 https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter_5 找到。